TrialBlood advances2020

Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders.

Mark T Vander Lugt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.